Annual Current Ratio
11.26
+0.58+5.43%
December 31, 2024
Summary
- As of March 12, 2025, SYRE annual current ratio is 11.26, with the most recent change of +0.58 (+5.43%) on December 31, 2024.
- During the last 3 years, SYRE annual current ratio has risen by +6.35 (+129.33%).
- SYRE annual current ratio is now -32.78% below its all-time high of 16.75, reached on December 1, 2016.
Performance
SYRE Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Ratio
11.26
+3.94+53.83%
December 31, 2024
Summary
- As of March 12, 2025, SYRE quarterly current ratio is 11.26, with the most recent change of +3.94 (+53.83%) on December 31, 2024.
- Over the past year, SYRE quarterly current ratio has stayed the same.
- SYRE quarterly current ratio is now -69.67% below its all-time high of 37.12, reached on March 1, 2015.
Performance
SYRE Quarterly Current Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Ratio Formula
Current Ratio = Current Assets
Current Liabilities
Current Assets
Current Liabilities
Current Liabilities
SYRE Current Ratio Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +5.4% | 0.0% |
| 3 y3 years | +129.3% | +142.2% |
| 5 y5 years | +177.3% | +142.2% |
SYRE Current Ratio Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +164.9% | -42.8% | +993.2% |
| 5 y | 5-year | at high | +177.3% | -42.8% | +993.2% |
| alltime | all time | -32.8% | +336.4% | -69.7% | +993.2% |
Spyre Therapeutics Current Ratio History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | 11.26(+5.4%) | 11.26(+53.8%) |
| Sep 2024 | - | 7.32(-62.8%) |
| Jun 2024 | - | 19.70(+73.1%) |
| Mar 2024 | - | 11.38(+6.6%) |
| Dec 2023 | 10.68(+151.3%) | 10.68(+132.7%) |
| Sep 2023 | - | 4.59(+345.6%) |
| Jun 2023 | - | 1.03(-70.7%) |
| Mar 2023 | - | 3.51(-17.4%) |
| Dec 2022 | 4.25(-13.4%) | - |
| Dec 2022 | - | 4.25(-8.6%) |
| Sep 2022 | - | 4.65(-23.6%) |
| Jun 2022 | - | 6.09(+36.9%) |
| Mar 2022 | - | 4.45(-9.4%) |
| Dec 2021 | 4.91(-46.1%) | 4.91(-14.6%) |
| Sep 2021 | - | 5.75(-11.8%) |
| Jun 2021 | - | 6.52(+39.3%) |
| Mar 2021 | - | 4.68(-48.6%) |
| Dec 2020 | 9.11(+124.4%) | 9.11(-9.4%) |
| Sep 2020 | - | 10.06(-1.3%) |
| Jun 2020 | - | 10.19(+221.5%) |
| Mar 2020 | - | 3.17(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | 4.06(-45.8%) | 4.06(-32.6%) |
| Sep 2019 | - | 6.02(-28.7%) |
| Jun 2019 | - | 8.44(-21.4%) |
| Mar 2019 | - | 10.74(+43.4%) |
| Dec 2018 | 7.49(-23.3%) | 7.49(-20.1%) |
| Sep 2018 | - | 9.37(-26.7%) |
| Jun 2018 | - | 12.78(+50.9%) |
| Mar 2018 | - | 8.47(-13.3%) |
| Dec 2017 | 9.77(-41.7%) | 9.77(-19.9%) |
| Sep 2017 | - | 12.20(-18.6%) |
| Jun 2017 | - | 14.98(-1.7%) |
| Mar 2017 | - | 15.24(-9.0%) |
| Dec 2016 | 16.75(+10.4%) | 16.75(-10.3%) |
| Sep 2016 | - | 18.68(-18.4%) |
| Jun 2016 | - | 22.88(+148.2%) |
| Mar 2016 | - | 9.22(-39.2%) |
| Dec 2015 | 15.17(+488.0%) | 15.17(-12.1%) |
| Sep 2015 | - | 17.25(+2.7%) |
| Jun 2015 | - | 16.80(-54.7%) |
| Mar 2015 | - | 37.12(+1338.8%) |
| Dec 2014 | 2.58(-20.9%) | 2.58 |
| Dec 2013 | 3.26 | - |
FAQ
- What is Spyre Therapeutics annual current ratio?
- What is the all time high annual current ratio for Spyre Therapeutics?
- What is Spyre Therapeutics annual current ratio year-on-year change?
- What is Spyre Therapeutics quarterly current ratio?
- What is the all time high quarterly current ratio for Spyre Therapeutics?
- What is Spyre Therapeutics quarterly current ratio year-on-year change?
What is Spyre Therapeutics annual current ratio?
The current annual current ratio of SYRE is 11.26
What is the all time high annual current ratio for Spyre Therapeutics?
Spyre Therapeutics all-time high annual current ratio is 16.75
What is Spyre Therapeutics annual current ratio year-on-year change?
Over the past year, SYRE annual current ratio has changed by +0.58 (+5.43%)
What is Spyre Therapeutics quarterly current ratio?
The current quarterly current ratio of SYRE is 11.26
What is the all time high quarterly current ratio for Spyre Therapeutics?
Spyre Therapeutics all-time high quarterly current ratio is 37.12
What is Spyre Therapeutics quarterly current ratio year-on-year change?
Over the past year, SYRE quarterly current ratio has changed by 0.00 (0.00%)